ID   PA2G5_HUMAN             Reviewed;         138 AA.
AC   P39877; Q8N435;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   15-MAR-2017, entry version 159.
DE   RecName: Full=Calcium-dependent phospholipase A2;
DE            EC=3.1.1.4;
DE   AltName: Full=Group V phospholipase A2;
DE   AltName: Full=PLA2-10;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 5;
DE   Flags: Precursor;
GN   Name=PLA2G5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Stomach;
RX   PubMed=8300559;
RA   Chen J., Engle S.J., Seilhamer J.J., Tischfield J.A.;
RT   "Cloning and recombinant expression of a novel human low molecular
RT   weight Ca(2+)-dependent phospholipase A2.";
RL   J. Biol. Chem. 269:2365-2368(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND VARIANTS FRFB CYS-45 AND SER-49.
RX   PubMed=22137173; DOI=10.1016/j.ajhg.2011.11.004;
RA   Sergouniotis P.I., Davidson A.E., Mackay D.S., Lenassi E., Li Z.,
RA   Robson A.G., Yang X., Kam J.H., Isaacs T.W., Holder G.E., Jeffery G.,
RA   Beck J.A., Moore A.T., Plagnol V., Webster A.R.;
RT   "Biallelic mutations in PLA2G5, encoding group V phospholipase A2,
RT   cause benign fleck retina.";
RL   Am. J. Hum. Genet. 89:782-791(2011).
CC   -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides. This isozyme hydrolyzes
CC       more efficiently L-alpha-1-palmitoyl-2-oleoyl phosphatidylcholine
CC       than L-alpha-1-palmitoyl-2-arachidonyl phosphatidylcholine, L-
CC       alpha-1-palmitoyl-2-arachidonyl phosphatidylethanolamine, or L-
CC       alpha-1-stearoyl-2-arachidonyl phosphatidylinositol. May be
CC       involved in the production of lung surfactant, the remodeling or
CC       regulation of cardiac muscle.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10035, ECO:0000255|PROSITE-ProRule:PRU10036}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.5. Activity remains high up to pH 9.0.;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Heart, placenta and less abundantly, in lung.
CC       Detected in the outer and inner plexiform layers of the retina (at
CC       protein level). {ECO:0000269|PubMed:22137173}.
CC   -!- PTM: This enzyme lacks one of the seven disulfide bonds found in
CC       similar PA2 proteins.
CC   -!- DISEASE: Fleck retina, familial benign (FRFB) [MIM:228980]: An
CC       autosomal recessive condition associated with a distinctive
CC       retinal appearance and no apparent visual or electrophysiologic
CC       deficits. Affected individuals are asymptomatic, but fundus
CC       examination reveals a striking pattern of diffuse, yellow-white,
CC       fleck-like lesions extending to the far periphery of the retina
CC       but sparing the foveal region. {ECO:0000269|PubMed:22137173}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pla2g5/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03090; AAC28886.1; -; mRNA.
DR   EMBL; AY524778; AAR92480.1; -; Genomic_DNA.
DR   EMBL; AL158172; CAC13158.1; -; Genomic_DNA.
DR   EMBL; BC036792; AAH36792.2; -; mRNA.
DR   CCDS; CCDS202.1; -.
DR   PIR; A49959; A49959.
DR   RefSeq; NP_000920.1; NM_000929.2.
DR   RefSeq; XP_005245950.1; XM_005245893.4.
DR   RefSeq; XP_011539889.1; XM_011541587.2.
DR   RefSeq; XP_011539890.1; XM_011541588.2.
DR   RefSeq; XP_011539891.1; XM_011541589.2.
DR   RefSeq; XP_011539892.1; XM_011541590.2.
DR   RefSeq; XP_011539893.1; XM_011541591.2.
DR   RefSeq; XP_011539894.1; XM_011541592.2.
DR   UniGene; Hs.319438; -.
DR   PDB; 2GHN; Model; -; A=21-138.
DR   PDBsum; 2GHN; -.
DR   ProteinModelPortal; P39877; -.
DR   SMR; P39877; -.
DR   STRING; 9606.ENSP00000364249; -.
DR   BindingDB; P39877; -.
DR   ChEMBL; CHEMBL4323; -.
DR   GuidetoPHARMACOLOGY; 1430; -.
DR   SwissLipids; SLP:000000140; -.
DR   BioMuta; PLA2G5; -.
DR   DMDM; 730258; -.
DR   PaxDb; P39877; -.
DR   PeptideAtlas; P39877; -.
DR   PRIDE; P39877; -.
DR   Ensembl; ENST00000375108; ENSP00000364249; ENSG00000127472.
DR   GeneID; 5322; -.
DR   KEGG; hsa:5322; -.
DR   UCSC; uc001bcy.4; human.
DR   CTD; 5322; -.
DR   DisGeNET; 5322; -.
DR   GeneCards; PLA2G5; -.
DR   HGNC; HGNC:9038; PLA2G5.
DR   HPA; HPA053361; -.
DR   MalaCards; PLA2G5; -.
DR   MIM; 228980; phenotype.
DR   MIM; 601192; gene.
DR   neXtProt; NX_P39877; -.
DR   OpenTargets; ENSG00000127472; -.
DR   Orphanet; 363989; Familial benign flecked retina.
DR   PharmGKB; PA33366; -.
DR   eggNOG; KOG4087; Eukaryota.
DR   eggNOG; ENOG411283D; LUCA.
DR   GeneTree; ENSGT00760000119160; -.
DR   HOGENOM; HOG000231749; -.
DR   HOVERGEN; HBG008137; -.
DR   InParanoid; P39877; -.
DR   KO; K01047; -.
DR   OMA; YCLKRNL; -.
DR   OrthoDB; EOG091G0UZ3; -.
DR   PhylomeDB; P39877; -.
DR   TreeFam; TF319283; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   GeneWiki; PLA2G5; -.
DR   GenomeRNAi; 5322; -.
DR   PRO; PR:P39877; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000127472; -.
DR   CleanEx; HS_PLA2G5; -.
DR   Genevisible; P39877; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; TAS:ProtInc.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:Ensembl.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; IEA:Ensembl.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:ProtInc.
DR   GO; GO:0006663; P:platelet activating factor biosynthetic process; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:CACAO.
DR   GO; GO:0010518; P:positive regulation of phospholipase activity; IDA:CACAO.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0034097; P:response to cytokine; IEA:Ensembl.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Complete proteome; Disease mutation;
KW   Disulfide bond; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    138       Calcium-dependent phospholipase A2.
FT                                /FTId=PRO_0000022761.
FT   ACT_SITE     67     67       {ECO:0000250}.
FT   ACT_SITE    111    111       {ECO:0000250}.
FT   METAL        47     47       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        49     49       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        51     51       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        68     68       Calcium. {ECO:0000250}.
FT   DISULFID     46    137       {ECO:0000250}.
FT   DISULFID     48     64       {ECO:0000250}.
FT   DISULFID     63    117       {ECO:0000250}.
FT   DISULFID     70    110       {ECO:0000250}.
FT   DISULFID     79    103       {ECO:0000250}.
FT   DISULFID     97    108       {ECO:0000250}.
FT   VARIANT      45     45       G -> C (in FRFB; dbSNP:rs387906795).
FT                                {ECO:0000269|PubMed:22137173}.
FT                                /FTId=VAR_067343.
FT   VARIANT      49     49       G -> S (in FRFB; dbSNP:rs387906796).
FT                                {ECO:0000269|PubMed:22137173}.
FT                                /FTId=VAR_067344.
SQ   SEQUENCE   138 AA;  15674 MW;  0D17DC76E55F42BC CRC64;
     MKGLLPLAWF LACSVPAVQG GLLDLKSMIE KVTGKNALTN YGFYGCYCGW GGRGTPKDGT
     DWCCWAHDHC YGRLEEKGCN IRTQSYKYRF AWGVVTCEPG PFCHVNLCAC DRKLVYCLKR
     NLRSYNPQYQ YFPNILCS
//
